<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20210701051754N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2021-07-07</date_registration>
      <primary_sponsor>Kharazmi University</primary_sponsor>
      <public_title>Effect of Pilates with pain education in improvement of knee osteoarthritis</public_title>
      <acronym></acronym>
      <scientific_title>Evaluation of adding Pain neuroscience education to Pilates exercises on reducing on pain and improving function and psychological variables in individuals with knee osteoarthritis</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2021-07-11</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>44</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/57239</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Following the baseline examination, by using the method shown on the website http://randomizer.org/ (Social Psychology Network, Connecticut, USA), participants will be randomly assigned into the pain neuroscience education plus Pilates exercises group and Pilates exercises group. Simple randomization will be used. Concealed allocation is performed using a computer-generated block randomized table of numbers (1 for pain neuroscience education plus Pilates exercises group and 2 for Pilates exercises group) created before the start of data collection by a researcher who is not involved in the recruitment or treatment of patients. Then, the random numerical sequence is placed in sealed opaque envelopes. Another researcher, blind to the baseline examination, open an envelope and process with treatment according to the group assignment. An independent assessor who is not known about the study’s hypothesis and methods and is blind to the treatment group, assess the outcome measures before the interventions, and 8 weeks after interventions, Blinding description: In this study, the outcome assessor was blinded of the process of randomization and division of individuals into two experimental and control groups.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Knee osteoarthritis.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Individuals in this group receive 3 sessions of pain neuroscience education and 24 session (for 8 weeks) Pilates exercises. Education includes 3 individualized sessions (30 and 60 minutes) held by a physical therapist. It reframes the patient's negative beliefs about pain by providing information about the nature of pain. This approach can reduce fear avoidance and avoidance behavior, and increase self-efficacy. Each Pilates exercises session (24 in total) will be held by a physical therapist and take 60 minutes including warm-up, exercises, and cool-down. The number of repetitions is started from 5 and  gradually increased according to the patient's ability. Exercises are based on the previous studies on knee osteoarthritis. Intervention 2: Control group: This group only receive Pilates exercises. Each Pilates exercises session (24 in total) will be held by a physical therapist and take 60 minutes including warm-up, exercises, and cool-down. The number of repetitions is started from 5 and  gradually increased according to the patient's ability. Exercises are based on the previous studies on knee osteoarthritis.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link>https://doi.org/10.1186/s13075-023-03079-7</results_url_link>
      <results_summary>Results
Significant within-group differences were observed in all outcomes in both groups at post-treatment. There were no statistically between-group differences in pain (adjusted mean difference: -0.8; 95% CI -2.2 to 0.7; p = 0.288), physical limitation (adjusted mean difference: -0.4; 95% CI -4 to 3.1; p = 0.812) and function (adjusted mean difference: -0.8; 95% CI -1.8 to 0.1; p = 0.069) at eight weeks. For pain catastrophizing (adjusted mean difference: -3.9; 95% CI -7.2 to -0.6; p = 0.021), kinesiophobia (adjusted mean difference: -4.2; 95% CI -8.1 to -0.4; p = 0.032), and self-efficacy (adjusted mean difference: 6.1; 95% CI 0.7 to 11.5; p = 0.028) statistically between-group improvements were observed favoring PNE followed by PEs group after the treatment.</results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Only demographic and outcomes-related data will be shared.

When:
After publishing paper(s) extracted from the study.

To whom:
The data can be displayed and shared at the reasonable request of the Iranian Clinical Trial Registration Center, journals, and university individuals /researchers who are conducting research and scientific activities in this field.

Conditions:
Data analysis and the use of documentation can only be done provided that their results are reported in systematic review articles by academic researchers and authors.

Requirements for sharing data and documents include:
1. Sending an email (preferably with valid university addresses) to one of the study researchers/authors
2. A brief and logical explanation of how to use the data or documentation
3. Ensuring that the protocol for systematic review studies, requesting access to data or documentation, is recorded.

Where to obtain:
Through asking from Authors

Pouya Rabiei
Pouya.rabiei.pr@gmail.com

Amir Letafatkar
letafatkaramir@yahoo.com

Bahram Sheikhi
sheikhibahram@gmail.com

How to obtain:
The applicant can request details from the researchers within 7 to 10 days using the message sent by email.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Amir Letafatkar</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Center for Human Movement Sciences Kharazmi University Mirdamad, Razan Street, Hesari Street,  Keshvari Sport complex Tehran, Iran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>15719-14911</zip>
        <telephone>+98 21 2222 8001</telephone>
        <email>letafatkaramir@yahoo.com</email>
        <affiliation>Kharazmi University</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Amir Letafatkar</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Center for Human Movement Sciences Kharazmi University Mirdamad, Razan Street, Hesari Street,  Keshvari Sport complex Tehran, Iran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>15719-14911</zip>
        <telephone>+98 21 2222 8001</telephone>
        <email>letafatkaramir@yahoo.com</email>
        <affiliation>Kharazmi University</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Being Persian-native speaker male and female
Being above 45 years old
Having primary complaint of knee pain diagnosed as knee OA (&gt;3 months’ duration) by an orthopedic physician.</inclusion_criteria>
      <agemin>45 years</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Having self-reported knee replacement or any other lower limb surgery 6 months prior to participation,
Having a history of inflammatory, metabolic or neurological disease,
Having knee ligament or meniscus injury in previous year,
Having any mental health conditions
Using therapeutic modalities 6 months before participation.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>M17</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Osteoarthritis of knee</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Individuals in this group receive 3 sessions of pain neuroscience education and 24 session (for 8 weeks) Pilates exercises. Education includes 3 individualized sessions (30 and 60 minutes) held by a physical therapist. It reframes the patient's negative beliefs about pain by providing information about the nature of pain. This approach can reduce fear avoidance and avoidance behavior, and increase self-efficacy. Each Pilates exercises session (24 in total) will be held by a physical therapist and take 60 minutes including warm-up, exercises, and cool-down. The number of repetitions is started from 5 and  gradually increased according to the patient's ability. Exercises are based on the previous studies on knee osteoarthritis.</i_keyword>
      <i_keyword>Control group: This group only receive Pilates exercises. Each Pilates exercises session (24 in total) will be held by a physical therapist and take 60 minutes including warm-up, exercises, and cool-down. The number of repetitions is started from 5 and  gradually increased according to the patient's ability. Exercises are based on the previous studies on knee osteoarthritis.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Pain intensity. Timepoint: Before the intervention and after 8 weeks after intervention. Method of measurement: Western Ontario and McMaster Universities Arthritis (WOMAC) Index.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Function. Timepoint: Before intervention and 8 weeks after intervention. Method of measurement: Timed “Up &amp; Go” (TUG) test.</sec_outcome>
      <sec_outcome>Pain Catastrophizing. Timepoint: Before intervention and 8 weeks after intervention. Method of measurement: Pain Catastrophizing Scale (PCS).</sec_outcome>
      <sec_outcome>Kinesiophobia. Timepoint: Before intervention and 8 weeks after intervention. Method of measurement: Tampa Scale for Kinesiophobia (TSK).</sec_outcome>
      <sec_outcome>Self-efficacy. Timepoint: Before intervention and 8 weeks after intervention. Method of measurement: Pain Self-Efficacy Questionnaire (PSEQ).</sec_outcome>
      <sec_outcome>Physical activity. Timepoint: Before intervention and 8 weeks after intervention. Method of measurement: Western Ontario and McMaster Universities Arthritis (WOMAC) Index.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>This study has been conducted by the researchers and no organizational fund has been received</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2021-05-19</approval_date>
        <contact_name>Sport Sciences Research Institute</contact_name>
        <contact_address>No. 3,  Fifth Alley, Mir Emad St., Ostad Motahari St., Tehran Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
